These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34478181)

  • 1. Synthesis of [
    Kriegelstein M; Hroch M; Marek A
    J Labelled Comp Radiopharm; 2021 Nov; 64(13):500-512. PubMed ID: 34478181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon-13 labeling of ibrutinib for human microdosing.
    Gong Y; Salter R
    J Labelled Comp Radiopharm; 2023 Jan; 66(1):4-10. PubMed ID: 36412065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases.
    Guo M; Dai S; Wu D; Duan Y; Li J; Qu L; Jiang L; Chen Z; Chen X; Chen Y
    Bioorg Med Chem Lett; 2021 Feb; 34():127757. PubMed ID: 33359446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.
    Ran F; Liu Y; Wang C; Xu Z; Zhang Y; Liu Y; Zhao G; Ling Y
    Eur J Med Chem; 2022 Feb; 229():114009. PubMed ID: 34839996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
    Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
    Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for isotope containment during radiosynthesis--devolatilisation of bromobenzene by fluorous-tagging-Ir-catalysed borylation en route to the 4-phenylpiperidine pharmacophore.
    Spivey AC; Martin LJ; Tseng CC; Ellames GJ; Kohler AD
    Org Biomol Chem; 2008 Nov; 6(22):4093-5. PubMed ID: 18972036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The syntheses of [
    Maxwell BD
    J Labelled Comp Radiopharm; 2017 Jun; 60(8):357-365. PubMed ID: 28273377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential adsorption of an analyte and its D
    Mžik M; Váňová N; Kriegelstein M; Hroch M
    J Pharm Biomed Anal; 2021 Nov; 206():114366. PubMed ID: 34555634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses of isotope-labeled SGLT2 inhibitor canagliflozin (JNJ-28431754).
    Lin R; Hoerr DC; Weaner LE; Salter R
    J Labelled Comp Radiopharm; 2017 Nov; 60(13):616-623. PubMed ID: 28833358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of stable isotope-labelled firocoxib.
    Latli B; Gao A; Kvaternick V; Tecle B; Pennino S; Yee NK; Song J
    J Labelled Comp Radiopharm; 2020 Jun; 63(8):386-392. PubMed ID: 32307719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact of BTK active site inhibitors on the conformational state of full-length BTK.
    Joseph RE; Amatya N; Fulton DB; Engen JR; Wales TE; Andreotti A
    Elife; 2020 Nov; 9():. PubMed ID: 33226337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoproteomic Profiling of an Ibrutinib Analogue Reveals its Unexpected Role in DNA Damage Repair.
    Ye Z; Wang Y; Wu H; Song T; Li X; Liu Q; Wang C
    Chembiochem; 2021 Jan; 22(1):129-133. PubMed ID: 32979005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected scientific topics of the 11th International Isotope Symposium on the Synthesis and Applications of Isotopes and Isotopically Labeled Compounds.
    Atzrodt J; Derdau V
    J Labelled Comp Radiopharm; 2013; 56(9-10):408-16. PubMed ID: 24285513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 13C and 15N labeled 2,4-dinitroanisole.
    Jagadish B; Field JA; Chorover J; Sierra-Alvarez R; Abrell L; Mash EA
    J Labelled Comp Radiopharm; 2014 May; 57(6):434-6. PubMed ID: 24596018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton exchange reactions in isotope chemistry (II) synthesis of stable isotope-labeled LCQ908.
    Jian Z; Ray T; Wu A; Jones L; Forseth R
    J Labelled Comp Radiopharm; 2014 Oct; 57(12):670-3. PubMed ID: 25314622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-scale synthesis and efficient purification of 13C-labeled levoglucosan from 13C glucose.
    Alexander L; Hoyt C; Michalczyk R; Wu R; Thorn DL; Silks LA
    J Labelled Comp Radiopharm; 2013 Jan; 56(1):27-9. PubMed ID: 24285138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase.
    Wang X; Wang Z; Fan X; Yan M; Jiang L; Xia Y; Cao J; Liu Y
    Toxicol Appl Pharmacol; 2021 Aug; 424():115595. PubMed ID: 34038714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The syntheses of isotopically labelled CB-1 antagonists for the treatment of obesity.
    Tran SB; Maxwell BD; Burrell R; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2016 Dec; 59(14):665-672. PubMed ID: 27624665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of
    Hesk D; Koharski D; McNamara P; Royster P; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2018 Jun; 61(7):533-539. PubMed ID: 29493011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia: one step ahead ibrutinib.
    Molica S; Gianfelici V; Levato L
    Expert Opin Emerg Drugs; 2020 Mar; 25(1):25-35. PubMed ID: 31996046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.